Frida Popilevsky, MD
Pulmonary Disease · Brooklyn, NYNPI 1104086156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boehringer Ingelheim accounts for 69.8% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for pulmonary disease clinicians in NY, where the typical reported total is $756.
Across 8 payments — averaging $110.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$618
- Olympus America Inc.$144
- La Jolla Pharmaceutical Company$123
What the payments were for
- Food & beverage$886100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 5 | $618 |
| Olympus America Inc. | 1 | $144 |
| La Jolla Pharmaceutical Company | 2 | $123 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$375
- SPiN Vision Video Processor$144
- GIAPREZA$110
How this compares
$886 in reported general payments places this provider in the 50th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Brooklyn
- Ali El AtatBrooklyn$482K
- Sunil MehraBrooklyn$388K
- Xiaojun YanBrooklyn$249K
- Boris SagalovichBrooklyn$212K
- Chaim BernsteinBrooklyn$186K
- Jeffrey WolfGreat Neck$892K
- Keith HarrisPort Jefferson Station$832K
- Jack MannBayside$736K
- Raji AyinlaBronx$673K
- Charles PowellNew York$654K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.